Navigation Links
Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
Date:9/16/2008

Technology Targets Tumors with Precise Image-Guided IMRT to Spare Healthy

Surrounding Tissue

PALO ALTO, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Doctors at cancer treatment centers in the United States and the Netherlands are now treating head and neck cancer using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). RapidArc was used to deliver ultra-precise image-guided intensity-modulated radiotherapy (IMRT) significantly faster than was previously possible with conventional IMRT. The RapidArc treatment plans for these cases also did a better job of protecting surrounding normal tissues and organs.

"Traditional IMRT has been a gold standard for several years in radiotherapy when it came to avoiding healthy tissue and targeting the tumor mass," said Ben Slotman, MD, PhD, professor and chairman of the Department of Radiation Oncology at the VU University Medical Center in Amsterdam, Netherlands. "We have been so satisfied with the faster treatment planning and the faster delivery with RapidArc that we plan to treat all of our head and neck IMRT candidates using this technology."

Slotman and his colleagues recently treated a 46-year old male with throat cancer. "The RapidArc plan showed better and more even tumor coverage, compared with a standard 7-field IMRT plan," said Slotman. "With RapidArc, we were also able to spare more of the organs at risk than with IMRT," he added. When treating a tumor in the head or neck it is important to avoid the highly sensitive organs nearby, such as the spinal cord, eyes, brainstem, and other vital areas of the central nervous system.

At the Center for Radiation Therapy of Beverly Hills, Henry Yampolsky, MD, recently used
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
2. Black Enterprise Unveils Americas Leading Doctors
3. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
4. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
5. Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
6. Start of First Fingertip Payment Pilot in the Netherlands
7. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
8. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
9. Alba Therapeutics Announces IND for Beta Cell Preservation in Type 1 Diabetes Using AT-1001
10. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
11. Using catalysts to stamp nanopatterns without ink

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... California waste-to-energy firm claims first pl...eration, smallest footprint, salable pure gas, byp... (PRWEB) December 15, 2009 -- The ...tive organic waste-to-energy process will take pla...uary. , , ,This biowaste process known as VRAD&co...
(Date:11/30/2009)...vember 30, 2009 An international team of applied ...ETH Zrich have demonstrated compact, multibeam, an...e part of the light spectrum (infrared). By contra...ell-defined wavelength. The innovative multibeam l...o remote chemical sensing pollution monitoring, op...
(Date:11/30/2009)...Nov. 30 The Michael J. ...ay announced $1.5 million in total awards to six r...se-modifying therapies for Parkinson,s disease. Th...to Drug Discovery for Parkinson,s Disease program...plc (NYSE: ELN ), a neuroscience-based biotechno...
(Date:11/30/2009)...DAM, November 30 Biopharmaceutical...rst patients have been enrolled in its,multination...study is,designed to show reduction in transplant ...n allogeneic stem cell transplantation with a mism...ients eligible for an allogeneic,stem cell transpl...
Breaking Biology Technology:First Public Showing of Innovative Waste-to-Energy Process 2Scientists demonstrate multibeam, multi-functional lasers 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2
...Appoints Business Leader as Interim President, HO... NBF ), a refiner and marketer of ASTM quality bi...senior executive team to include Fred,Zeidman as i...director,since June 26, 2007. He has served as a M..., LLP since July 2003 and as Chairman of the Board...
...PRINCETON, N.J., March 20 Medarex, Inc.,(Nasdaq: ...estone payment of,an undisclosed amount from its l...on of a Marketing Authorization Application to the...golimumab (CNTO 148) for the,treatment of rheumato...pondylitis., Golimumab is a human anti-TNF monocl...
...Biologically active tissue adhesive allows for pla...t staples or sutures, DEERFIELD, Ill., March 20 ...U.S. Food and Drug Administration (FDA),approval o...nly,slow-setting fibrin sealant indicated for use ...n patients. ARTISS was developed using Baxter,s,pr...
Other Biology Technology:Nova Biosource Fuels Expands Senior Executive Team 2Nova Biosource Fuels Expands Senior Executive Team 3Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients 2Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients 3
(Date:11/30/2009)...ve review of the state of Antarctica,s climate and...published this week (Tuesday 1 December) by the Sc...The review - Antarctic Climate Change and the Envi... continent, identifies areas for future scientific... policy makers have about Antarctic melting, sea-l...
(Date:11/30/2009)...from The Forsyth Institute, the University of Conn...enter, have used state-of-the-art technology to el...llidum, the bacterium which causes syphilis. The p...ia can now be shown in three dimensions. This prov...als previously unknown features, which may help fi...
(Date:11/30/2009)...archers from LSU Health Sciences Center New Orlean...National Institute of Child Health and Human Devel...righam and Women,s Hospital, and Harvard Medical S... more than 5 servings of sugar- sweetened cola a w...evate the risk of developing diabetes during pregn...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3N2Care Unveils Backyard Smart MEDcottage 54880 1N2Care Unveils Backyard Smart MEDcottage 54880 2Purple Communications Invites Greater San Ramon Community to Celebrate Ms Ella Mae Lentz Finalist in Dream Bigger Initiative 54878 1Purple Communications Invites Greater San Ramon Community to Celebrate Ms Ella Mae Lentz Finalist in Dream Bigger Initiative 54878 2Purple Communications Invites Greater San Ramon Community to Celebrate Ms Ella Mae Lentz Finalist in Dream Bigger Initiative 54878 3Purple Communications Invites Greater San Ramon Community to Celebrate Ms Ella Mae Lentz Finalist in Dream Bigger Initiative 54878 4Purple Communications Invites Greater San Ramon Community to Celebrate Ms Ella Mae Lentz Finalist in Dream Bigger Initiative 54878 5Physicians Citing Human Error as Top Communication Problem 54876 1Physicians Citing Human Error as Top Communication Problem 54876 2
...Exposure to levels of radon gas typically found in...e risk of developing lung cancer by as much as 60 ...ch 2008 issue of the journal Health Physics. The f...revious case-control studies of the effects of low...tly elevated lung cancer risk (but without statist...
...g the process for forming compounds that can be us...als and plastics, has earned one University of Hou...lis, assistant professor of chemistry in the Colle...mong 118 outstanding young scientists, mathematici... to be named an Alfred P. Sloan Research Fellow fo...
...s of previously-unreported callus hairs growing in...lated varieties, which may have storage implicatio...g new about apples is really exciting, says Dr Mar... have been cultivated for about as long as human h... their crispness, sweet flavour and keeping qualit...
Other Biology News:Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 2Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 4Simplifying manufacture of drugs, plastics earns UH chemist top honor 2Popular apple variety harbors unusual cell growth 2
Mouse Anti-Human NR4A2 Monoclonal Antibody, Unconjugated, Clone 3E10 from Abnova Corporation
...em for detection of very low level of luminescent ...sensitive camera to detect low level light in anim...e research, gene expression, circadian rhythm or W...otor-driven camera inside the light-tight cabinet....
...lyzer and Sorter) large particle flow cytometers f...cytometry to applications that were not previously... and sorting. Our instruments are based on the sa...are designed to accommodate much larger objects, u...
Mouse Anti-Human LDB3 Monoclonal Antibody, Unconjugated, Clone 3C8 from Abnova Corporation
Biology Products: